Nestle raises stake in food allergy drug developer Aimmune Medical Dialogues Bureau13 Nov 2018 10:23 AM GMTThe health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to...